Easywell Biomedicals Performance dei guadagni passati
Il passato criteri di controllo 0/6
Easywell Biomedicals has been growing earnings at an average annual rate of 5.8%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been declining at an average rate of 10.2% per year.
Informazioni chiave
5.8%
Tasso di crescita degli utili
16.0%
Tasso di crescita dell'EPS
| Medical Equipment Crescita del settore | 11.5% |
| Tasso di crescita dei ricavi | -10.2% |
| Rendimento del capitale proprio | -22.4% |
| Margine netto | -39.1% |
| Ultimo aggiornamento sui guadagni | 30 Jun 2024 |
Aggiornamenti sulle prestazioni recenti
Ripartizione dei ricavi e delle spese
Come Easywell Biomedicals guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
| Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Jun 24 | 361 | -141 | 96 | 293 |
| 31 Mar 24 | 308 | -144 | 81 | 284 |
| 31 Dec 23 | 272 | -145 | 62 | 271 |
| 30 Sep 23 | 241 | -146 | 30 | 250 |
| 30 Jun 23 | 215 | -145 | 26 | 224 |
| 31 Mar 23 | 181 | -158 | 23 | 215 |
| 31 Dec 22 | 179 | -161 | 28 | 209 |
| 30 Sep 22 | 149 | -159 | 27 | 213 |
| 30 Jun 22 | 149 | -184 | 25 | 227 |
| 31 Mar 22 | 161 | -208 | 26 | 235 |
| 31 Dec 21 | 197 | -150 | 24 | 238 |
| 30 Sep 21 | 247 | -127 | 24 | 224 |
| 30 Jun 21 | 240 | -130 | 25 | 216 |
| 31 Mar 21 | 261 | -123 | 24 | 222 |
| 31 Dec 20 | 268 | -173 | 21 | 222 |
| 30 Sep 20 | 269 | -244 | 21 | 233 |
| 30 Jun 20 | 314 | -242 | 23 | 232 |
| 31 Mar 20 | 354 | -239 | 25 | 222 |
| 31 Dec 19 | 360 | -242 | 26 | 225 |
| 30 Sep 19 | 420 | -140 | 30 | 216 |
| 30 Jun 19 | 434 | -112 | 28 | 220 |
| 31 Mar 19 | 411 | -110 | 30 | 221 |
| 31 Dec 18 | 419 | -104 | 34 | 210 |
| 30 Sep 18 | 343 | -191 | 39 | 245 |
| 30 Jun 18 | 346 | -244 | 42 | 273 |
| 31 Mar 18 | 370 | -260 | 47 | 285 |
| 31 Dec 17 | 374 | -292 | 54 | 308 |
| 30 Sep 17 | 407 | -322 | 68 | 288 |
| 30 Jun 17 | 439 | -305 | 86 | 260 |
| 31 Mar 17 | 401 | -292 | 96 | 231 |
| 31 Dec 16 | 328 | -255 | 104 | 183 |
| 30 Sep 16 | 314 | -198 | 97 | 152 |
| 30 Jun 16 | 266 | -163 | 90 | 116 |
| 31 Mar 16 | 363 | -144 | 85 | 96 |
| 31 Dec 15 | 468 | -145 | 82 | 89 |
| 30 Sep 15 | 530 | -114 | 90 | 72 |
| 30 Jun 15 | 486 | -116 | 82 | 58 |
| 31 Mar 15 | 337 | -97 | 74 | 42 |
| 31 Dec 14 | 227 | -85 | 62 | 28 |
| 30 Sep 14 | 94 | -145 | 54 | 30 |
| 30 Jun 14 | 85 | -132 | 51 | 34 |
| 31 Mar 14 | 96 | -137 | 48 | 39 |
| 31 Dec 13 | 100 | -132 | 45 | 48 |
Guadagni di qualità: 1799 is currently unprofitable.
Margine di profitto in crescita: 1799 is currently unprofitable.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: 1799 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.8% per year.
Accelerare la crescita: Unable to compare 1799's earnings growth over the past year to its 5-year average as it is currently unprofitable
Guadagni vs Settore: 1799 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.5%).
Rendimento del capitale proprio
ROE elevato: 1799 has a negative Return on Equity (-22.45%), as it is currently unprofitable.